What is Conventus Orthopaedics?
Conventus Orthopaedics, Inc. operates at the intersection of clinical innovation and medical device engineering, specifically targeting the complex and fragility fracture market. The company's core value proposition centers on its proprietary Conventus CAGE technology, which is designed to provide a superior standard of care compared to traditional treatment modalities. By focusing on unmet clinical needs, the firm aims to improve patient outcomes while simultaneously enhancing the surgeon experience and delivering measurable economic value to healthcare stakeholders. Its market position is defined by a rigorous focus on high-impact, life-changing medical solutions that address the growing demand for advanced orthopaedic interventions.
How much funding has Conventus Orthopaedics raised?
Conventus Orthopaedics has raised a total of $113.8M across 8 funding rounds:
Private Equity
$7.5M
Debt
$5.4M
Other Financing Round
$11.5M
Debt
$10M
Series A
$24M
Series B
$23.4M
Series C
$20M
Debt
$12M
Private Equity (2009): $7.5M, investors not publicly disclosed
Debt (2012): $5.4M, investors not publicly disclosed
Other Financing Round (2013): $11.5M supported by SightLine Partners, Spray Venture Partners, and Blue Sky Private Equity
Debt (2014): $10M featuring Oxford Finance and Square 1 Bank
Series A (2014): $24M backed by SightLine Partners, Deerfield, BioStar Capital, Ally Bridge Group, and Bluestem Capital
Series B (2015): $23.4M, investors not publicly disclosed
Series C (2017): $20M led by Deerfield and Sightline Partners
Debt (2017): $12M supported by Horizon Technology Finance Corporation
Key Investors in Conventus Orthopaedics
SightLine Partners
An alternative investment manager specializing in secondary buyouts and joint venture transactions within the medical technology and life sciences sectors.
Deerfield
A prominent healthcare investment firm that utilizes AI, data, and market research to advance innovation across the healthcare ecosystem.
Horizon Technology Finance Corporation
A specialty finance company providing structured debt financing and venture lending solutions to high-growth companies in the life sciences and technology sectors.
What's next for Conventus Orthopaedics?
With the infusion of recent capital, Conventus Orthopaedics is well-positioned to accelerate its commercialization strategy and expand its footprint within the global orthopaedic market. The company's strategic roadmap likely involves deepening its clinical evidence base, scaling manufacturing capabilities to meet demand, and potentially exploring new indications for its CAGE technology. Given the firm's history of securing both equity and debt financing, management is expected to maintain a disciplined approach to capital allocation, focusing on initiatives that drive long-term value creation and sustainable growth. As the company continues to mature, its ability to leverage existing investor relationships and clinical partnerships will be paramount in navigating the competitive landscape of medical technology.
See full Conventus Orthopaedics company page
